ROYAL BRISBANE AND WOMEN'S HOSPITAL
🇦🇺Australia
- Country
- 🇦🇺Australia
- Ownership
- -
- Established
- 2003-01-01
- Employees
- -
- Market Cap
- -
Kazia Therapeutics Launches Phase 1b Trial of Paxalisib with Immunotherapy for Advanced Breast Cancer
• Kazia Therapeutics has initiated the ABC-Pax trial to evaluate paxalisib combined with immunotherapy in advanced breast cancer patients.
• The Phase 1b study will assess the safety and efficacy of paxalisib with pembrolizumab or olaparib in triple-negative breast cancer.
• The trial utilizes a novel liquid biopsy platform for real-time monitoring of cancer and immune cell behavior during treatment.
• This combination aims to reprogram dormant cancer cells, making them susceptible to immune attack, potentially improving patient outcomes.
© Copyright 2025. All Rights Reserved by MedPath